Jens Cosedis Nielsen
0000-0001-9414-1653
Publication & Citation Trends
Publications
0 total
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
Cited by 1
Semantic Scholar
Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study
Cited by 1
Semantic Scholar
Atrial fibrillation and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: insights from the DANISH trial
Cited by 0
Semantic Scholar
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial.
Cited by 1
Semantic Scholar
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA.
Cited by 1
Semantic Scholar
PRevention Of sudden cardiac death aFter myocardial Infarction by Defibrillator im-plantation: Design and Rationale of the PROFID EHRA randomised clinical trial.
Cited by 4
Semantic Scholar
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial.
Cited by 26
Semantic Scholar
Research Topics
Cardiac pacing and defibrillation studies
(291)
Cardiac Arrhythmias and Treatments
(254)
Atrial Fibrillation Management and Outcomes
(132)
Cardiac electrophysiology and arrhythmias
(105)
Cardiovascular Function and Risk Factors
(57)
Affiliations
Statens Serum Institut
Linköping University
Université de Tours
Boston University
University of Modena and Reggio Emilia